Gut Microbiota Composition and Fecal Metabolic Phenotype in Patients With Acute Anterior Uveitis/Experiment 5

From BugSigDB


Reviewed Marked as Reviewed by KateRasheed on 2025-8-12

Curated date: 2025/07/16

Curator: Anne-mariesharp

Revision editor(s): Anne-mariesharp

Subjects

Location of subjects
China
Host species Species from which microbiome was sampled. Contact us to have more species added.
Homo sapiens
Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
Feces Cow dung,Cow pat,Droppings,Dung,Excrement,Excreta,Faeces,Fecal material,Fecal matter,Fewmet,Frass,Guano,Matières fécales@fr,Merde@fr,Ordure,Partie de la merde@fr,Piece of shit,Porción de mierda@es,Portion of dung,Portion of excrement,Portion of faeces,Portion of fecal material,Portion of fecal matter,Portion of feces,Portion of guano,Portion of scat,Portionem cacas,Scat,Spoor,Spraint,Stool,Teil der fäkalien@de,Feces,feces
Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
Anterior uveitis anterior uveitis,anterior uveitis (disease),Anterior uveitis [Ambiguous],Anterior uveitis, NOS,iridocyclitis,Uveitis, Anterior,Anterior uveitis
Group 0 name Corresponds to the control (unexposed) group for case-control studies
HLA-B27- (Human Leukocyte Antigen B27 negative) patients
Group 1 name Corresponds to the case (exposed) group for case-control studies
HLA-B27+ (Human Leukocyte Antigen B27 positive) patients
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
Acute Anterior Uveitis patients that tested positive for Human Leukocyte Antigen B27 (HLA-B27)
Group 0 sample size Number of subjects in the control (unexposed) group
8
Group 1 sample size Number of subjects in the case (exposed) group
28
Antibiotics exclusion Number of days without antibiotics usage (if applicable) and other antibiotics-related criteria used to exclude participants (if any)
3 months

Lab analysis

Sequencing type
16S
16S variable region One or more hypervariable region(s) of the bacterial 16S gene
V3-V4
Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
Illumina

Statistical Analysis

Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
relative abundances
Statistical test
Kruskall-Wallis
Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
0.05
MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
No


Signature 1

Reviewed Marked as Reviewed by KateRasheed on 2025-8-12

Curated date: 2025/07/16

Curator: Anne-mariesharp

Revision editor(s): Anne-mariesharp

Source: Table S4

Description: List of significantly different gut microbiota between HLA-B27+ patients and HLA-B27- patients

Abundance in Group 1: decreased abundance in HLA-B27+ (Human Leukocyte Antigen B27 positive) patients

NCBI Quality ControlLinks
Bifidobacterium
Blautia
Collinsella

Revision editor(s): Anne-mariesharp